hapten-based vaccine development

Design-Zyme LLC is a specialized vertically-integrated biotech founded in 2015 at the KU Innovation Park, Lawrence, Kansas. It has developed a patented multivalent vaccine platform delivering multivalent hapten vaccines for small molecule targets or multivalent protein immunogen vaccines for pathogenic threats. Its pipeline addresses opioid use disorder (DZ-XNF1), emerging drug threats in West & Central Africa (DZ-KU1), Lyme disease (DZ-LD1), and fescue toxicosis in livestock (DZ-FT1).

Read more

adjuvant solutionsdata-driven researchmultivalent nanoparticle approachesvaccine development